Jessica Thurmond, Program Director, Site Solutions & Strategic Partnering at WCG, shared a post on LinkedIn:
“Anyone who knows me, knows I spend most of my time entrenched in process and strategy. Over the last few years that focus has been almost exclusively on how we better align as an industry to reduce time to activation when a “one size fits all” approach simply isn’t feasible. If you know one site, you know one site.
I’m extremely grateful for the work of the AACI (Association of American Cancer Institutes) highlighting this has a central driver behind our ability to succeed on behalf of patients and innovation. A huge thank you to the AACI CRI Trial Activation Task Force for giving me the opportunity to serve as a collaborator on this paper.
On the heels of this release, I am also thrilled to be headed to AACI-CRI next week where I will be presenting beside my amazing colleagues from Yale Cancer Center and the work they’ve done in partnership to reduce time to activation! More to come and we’ll see you in Rosemont.”